BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37931691)

  • 1. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway.
    Mi K; Zeng L; Chen Y; Ning J; Zhang S; Zhao P; Yang S
    Cell Signal; 2024 Jan; 113():110962. PubMed ID: 37931691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
    Zhang LN; Zhao L; Yan XL; Huang YH
    J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of G3BP1 associates with YB1 and p-AKT and predicts poor prognosis in nonsmall cell lung cancer patients after surgical resection.
    Zheng H; Zhan Y; Zhang Y; Liu S; Lu J; Yang Y; Wen Q; Fan S
    Cancer Med; 2019 Nov; 8(16):6894-6903. PubMed ID: 31560169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas.
    Wang Y; Fu D; Chen Y; Su J; Wang Y; Li X; Zhai W; Niu Y; Yue D; Geng H
    Cell Death Dis; 2018 May; 9(5):501. PubMed ID: 29717134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of G3BP1 facilitates the progression of colon cancer by activating β‑catenin signaling.
    Li Y; Wang J; Zhong S; Li J; Du W
    Mol Med Rep; 2020 Nov; 22(5):4403-4411. PubMed ID: 33000280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) inhibits the progression of ovarian cancer in coordination with ubiquitin-specific protease 10 (USP10).
    Li M; Tang Y; Zuo X; Meng S; Yi P
    Bioengineered; 2022 Jan; 13(1):721-734. PubMed ID: 34967276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G3BP1 Depletion Increases Radiosensitisation by Inducing Oxidative Stress in Response to DNA Damage.
    Cho E; Than TT; Kim SH; Park ER; Kim MY; Lee KH; Shin HJ
    Anticancer Res; 2019 Nov; 39(11):6087-6095. PubMed ID: 31704836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2/STAT3 Signaling Pathway.
    Zhan Y; Wang W; Wang H; Xu Y; Zhang Y; Ning Y; Zheng H; Luo J; Yang Y; Zang H; Zhou M; Fan S
    Int J Biol Sci; 2024; 20(1):94-112. PubMed ID: 38164170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small nucleolar RNA SNORA71A promotes epithelial-mesenchymal transition by maintaining ROCK2 mRNA stability in breast cancer.
    Hu T; Lu C; Xia Y; Wu L; Song J; Chen C; Wang Q
    Mol Oncol; 2022 May; 16(9):1947-1965. PubMed ID: 35100495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1.
    Wang C; Wang J; Shen X; Li M; Yue Y; Cheng X; Lu W; Wang X; Xie X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):101. PubMed ID: 33726799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancer (EC) derived G3BP1 overexpression and mutant promote EC tumorigenesis and metastasis via SPOP/ERα axis.
    Ge Y; Jin J; Chen G; Li J; Ye M; Jin X
    Cell Commun Signal; 2023 Oct; 21(1):303. PubMed ID: 37904149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis.
    Li C; Pan B; Wang X; Liu X; Qin J; Gao T; Sun H; Pan Y; Wang S
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):1965-1982. PubMed ID: 35357586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orf Virus ORF120 Protein Positively Regulates the NF-κB Pathway by Interacting with G3BP1.
    Zhou Y; Guan J; Gao F; Li Z; Lan Y; Lu H; Song D; Lv L; Lv P; Xu M; Wang Z; He H; Zhao K; He W
    J Virol; 2021 Sep; 95(19):e0015321. PubMed ID: 34287041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
    Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
    Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of G3BP1 in human diseases (review).
    Ge Y; Jin J; Li J; Ye M; Jin X
    Gene; 2022 May; 821():146294. PubMed ID: 35176431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
    Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
    J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR-370-3p/SNAIL axis by inducing cell epithelial-mesenchymal transition (EMT).
    Long X; Wang DG; Wu ZB; Liao ZM; Xu JJ
    Cancer Med; 2023 Apr; 12(7):8289-8305. PubMed ID: 36530171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53.
    Mao C; Wang X; Liu Y; Wang M; Yan B; Jiang Y; Shi Y; Shen Y; Liu X; Lai W; Yang R; Xiao D; Cheng Y; Liu S; Zhou H; Cao Y; Yu W; Muegge K; Yu H; Tao Y
    Cancer Res; 2018 Jul; 78(13):3484-3496. PubMed ID: 29588351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.